These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 11563286)

  • 1. Effect of Fasudil HCl, a protein kinase inhibitor, on cerebral vasospasm.
    Shibuya M; Asano T; Sasaki Y
    Acta Neurochir Suppl; 2001; 77():201-4. PubMed ID: 11563286
    [No Abstract]   [Full Text] [Related]  

  • 2. Continuous intravertebral artery injection of fasudil hydrochloride in the treatment of cerebral vasospasm.
    Sarica FB
    Neurol India; 2011; 59(2):151-3. PubMed ID: 21483106
    [No Abstract]   [Full Text] [Related]  

  • 3. [Development of drug delivery system for intrathecal administration and its therapeutic effect on cerebral vasospasm and ischemia].
    Ishida T
    Yakugaku Zasshi; 2004 Aug; 124(8):541-7. PubMed ID: 15297723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protein kinase drugs--optimism doesn't wait on facts.
    Groom CR; Hopkins AL
    Drug Discov Today; 2002 Aug; 7(15):801-2. PubMed ID: 12546964
    [No Abstract]   [Full Text] [Related]  

  • 5. Intra-arterial Administration of Fasudil Hydrochloride for Vasospasm Following Subarachnoid Haemorrhage: Experience of 90 Cases.
    Iwabuchi S; Yokouchi T; Hayashi M; Sato K; Saito N; Hirata Y; Harashina J; Nakayama H; Akahata M; Ito K; Kimura H; Aoki K
    Acta Neurochir Suppl; 2011; 110(Pt 2):179-81. PubMed ID: 21125468
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuous intravertebral injection of fasudil hydrochloride in the treatment of cerebral vasospasm.
    Liu P; Liao X; Xiang J; Pan L; Ma L
    Neurol India; 2011; 59(2):161-7. PubMed ID: 21483110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of cerebral vasospasm with intra-arterial fasudil hydrochloride.
    Tanaka K; Minami H; Kota M; Kuwamura K; Kohmura E
    Neurosurgery; 2005 Feb; 56(2):214-23; discussion 214-23. PubMed ID: 15670369
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid hemorrhage - analysis of time-density curve with digital subtraction angiography.
    Iwabuchi S; Yokouchi T; Hayashi M; Uehara H; Ueda M; Samejima H
    Neurol Med Chir (Tokyo); 2006 Nov; 46(11):535-9; discussion 540. PubMed ID: 17124368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined administration of Fasudil hydrochloride and nitroglycerin for treatment of cerebral vasospasm.
    Tanaka Y; Masuzawa T; Saito M; Yamada T; Ebihara A; Iwasa H; Mori S
    Acta Neurochir Suppl; 2001; 77():205-7. PubMed ID: 11563287
    [No Abstract]   [Full Text] [Related]  

  • 10. [Intra-arterial administration of fasudil hydrochloride: duration of action].
    Ono K; Shirotani T; Wada K; Takahara T; Matsushita Y; Yuba K; Yamana D
    No Shinkei Geka; 2005 Feb; 33(2):133-40. PubMed ID: 15714958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein kinase inhibition by fasudil hydrochloride promotes neurological recovery after spinal cord injury in rats.
    Hara M; Takayasu M; Watanabe K; Noda A; Takagi T; Suzuki Y; Yoshida J
    J Neurosurg; 2000 Jul; 93(1 Suppl):94-101. PubMed ID: 10879764
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of fasudil hydrochloride, a protein kinase inhibitor, on cerebral vasospasm and delayed cerebral ischemic symptoms after aneurysmal subarachnoid hemorrhage.
    Zhao J; Zhou D; Guo J; Ren Z; Zhou L; Wang S; Xu B; Wang R
    Neurol Med Chir (Tokyo); 2006 Sep; 46(9):421-8. PubMed ID: 16998274
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppression of HIV-1 replication in peripheral blood mononuclear cells by fasudil.
    Akari H; Yamamoto Y; Hiwada H; Saito Y; Takayanagi N; Koyama AH; Adachi A
    J Med Invest; 1998 Feb; 44(3-4):211-4. PubMed ID: 9597811
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm.
    Mohri M; Shimokawa H; Hirakawa Y; Masumoto A; Takeshita A
    J Am Coll Cardiol; 2003 Jan; 41(1):15-9. PubMed ID: 12570938
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety and efficacy of fasudil monotherapy and fasudil-ozagrel combination therapy in patients with subarachnoid hemorrhage: sub-analysis of the post-marketing surveillance study.
    Suzuki Y; Shibuya M; Satoh S; Sugiyama H; Seto M; Takakura K
    Neurol Med Chir (Tokyo); 2008 Jun; 48(6):241-7; discussion 247-8. PubMed ID: 18574328
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Convulsion during intra-arterial infusion of fasudil hydrochloride for the treatment of cerebral vasospasm following subarachnoid hemorrhage.
    Enomoto Y; Yoshimura S; Yamada K; Iwama T
    Neurol Med Chir (Tokyo); 2010 Jan; 50(1):7-11; discussion 11-2. PubMed ID: 20098018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic intra-arterial administration of fasudil hydrochloride for vasospasm following subarachnoid haemorrhage.
    Iwabuchi S; Hayashi M; Yokouchi T; Sato K; Nakayama H; Harashina J; Iwama J; Ishii M; Hiramoto Y; Hirai N; Hirata Y; Saito N; Ito K; Kimura H; Aoki K
    Acta Neurochir Suppl; 2015; 120():167-9. PubMed ID: 25366618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antivasospastic effects of hydroxyfasudil, a Rho-kinase inhibitor, after subarachnoid hemorrhage.
    Satoh S; Takayasu M; Kawasaki K; Ikegaki I; Hitomi A; Yano K; Shibuya M; Asano T
    J Pharmacol Sci; 2012; 118(1):92-8. PubMed ID: 22186620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systematic assessment and meta-analysis of the efficacy and safety of fasudil in the treatment of cerebral vasospasm in patients with subarachnoid hemorrhage.
    Liu GJ; Wang ZJ; Wang YF; Xu LL; Wang XL; Liu Y; Luo GJ; He GH; Zeng YJ
    Eur J Clin Pharmacol; 2012 Feb; 68(2):131-9. PubMed ID: 21837395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical effect of Fasudil hydrochloride for cerebral vasospasm following subarachnoid hemorrhage.
    Masaoka H; Takasato Y; Nojiri T; Hayakawa T; Akimoto H; Yatsushige H; Toumori H; Miyazaki Y; Honma M
    Acta Neurochir Suppl; 2001; 77():209-11. PubMed ID: 11563288
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.